Market Value: Neumora Corp (NMRA)

Public company logo of Neumora Therapeutics, Inc. (NMRA)

The Neumora Therapeutics (NMRA) price chart demonstrates the market position of the company, which has a capitalization of 0.08. The business is currently focused on completing the final tests for the antidepressant navacaprant. The development of targeted psychiatric treatments relies on AI-driven biomarker analysis and patent protection. High medical research costs and the complexities of CNS therapy limit market access for new players.

Neumora Therapeutics, Inc. - NMRA Market Capitalization (period 02/21/2024 - 11/15/2026)

NMRA (Neumora Therapeutics, Inc.): analytical breakdowns and indicator data

- market price and analyst price targets:
- company stock exchange capitalization indicators:
Fundamental company analysis:NMRA (Neumora Therapeutics Inc)
Product sample of neumoratx.com

The valuation of Neumora Therapeutics (NMRA) depends directly on the success of clinical trials for depression and schizophrenia drugs. Market capitalization aggregates the value of all shares, reflecting the market's real-time assessment of the business. It is critical for investors to weigh this aggregate against macroeconomic risks and currency revaluation. The asset's price action allows for the separation of short-term noise from fundamental trends. Analyze this valuation chart to verify the impact of catalysts on capital.

Key competitors

Market Capitalization BIIB (Biogen Idec)|Neurocrine Biosciences Inc - Market Value|regencellbioscience.com - Market Capitalization|Market Capitalization axsome.com AXSM|ACAD: Market Capitalization|Market Value Xenon Pharmaceuticals Inc. (XENE)|Market Value Viking Therapeutics|Market Capitalization SUPN (Supernus Pharma)|Market Capitalization CPRX|DNLI - Market Value|harmonybiosciences.com - Market Valuation|Market Capitalization Biohaven Ltd BHVN|AMLX - Market Value|Market Value TRVI (Trevi Corp)|Praxis Precision Medicines Inc (PRAX) - Market Value|Market Value Anavex Life Sciences (AVXL)|CBLL (CeriBell Inc) - Market Capitalization|Prothena Corporation - Market Valuation|Market Value Alector (ALEC)|Annexon Biosciences Inc. - Market Capitalization|Market Capitalization OMER (Omeros)|Market Capitalization neurogene.com NGNE|AC Immune S.A. - Market Capitalization|VYGR - Market Capitalization|SCLX: Market Capitalization|Market Capitalization Tevogen Bio Holdings, Inc. TVGN|Market Valuation ACOG|CGTX (Cognition Therapeutics, Inc.) - Market Value|Market Capitalization IKT|Market Capitalization Cassava (SAVA)|Market Value Assertio ASRT|Coya Therapeutics, Inc. (COYA) - Market Value|VTGN: Market Valuation|Market Value OVID (ovidrx.com)|ABOS: Market Capitalization|CRVO - Market Capitalization|ATHE (alteritytherapeutics.com) - Market Capitalization|Market Valuation clene.com (CLNN)|Market Value pepgen.com (PEPG)|JUNS (Jupiter Neurosciences, Inc.) - Market Value|Market Capitalization RLMD (relmada.com)|Market Capitalization Annovis Bio Inc (ANVS)|GRCE: Market Valuation|Market Capitalization Firefly Neuroscience Inc AIFF|KLTO: Market Capitalization|NeuroSense Therapeutics Ltd - Market Value|Market Valuation RVPH|Market Capitalization MTVA (MetaVia Inc)|Market Value NeurAxis Inc (NRXS)|Helius Medical Technologies Inc. - Market Capitalization|Market Capitalization PASG (Passage Bio Inc.)|Market Capitalization bionomics.com.au NEUP|Minerva Neurosciences Inc - Market Capitalization|ATHA - Market Capitalization|ADXN: Market Capitalization|Alzamend (ALZN) - Market Capitalization|CYCN (cyclerion.com) - Market Capitalization|Protagenic Therapeutics (PTIX) - Market Capitalization|Market Value pasitheaclinics.com (KTTA)|CRGT (Cortigent Inc) - Market Value|Market Capitalization ATXI (Avenue Therapeutics Inc)|Market Value BCLI|Cara Therapeutics Inc - Market Capitalization|Chromocell Therapeutics (CHRO) - Market Valuation|ELYM (Eliem Therapeutics Inc.) - Market Valuation|ITCI - Market Capitalization|Market Value Longboard Pharma|Market Capitalization MRNS (Marinus Pharma)|Market Value NKGen Biotech Inc (NKGN)|NRBO - Market Value|Market Capitalization SAGE (Sage Therapeutics Inc)|Synaptogenix Inc. (SNPX) - Market Value|TRVN: Market Valuation|Market Capitalization vigilneuro.com VIGL|WENA (Anew Medical Inc.) - Market Valuation|Market Valuation Cerevel Therapeutics